|
JP2009298812A
|
|
Nontoxic mucosal adjuvant
|
|
GB0607738D0
|
|
Modification of capsular saccharides
|
|
GB0605757D0
|
|
Separation of conjugated and unconjugated components
|
|
GB0605247D0
|
|
Compositions and methods for immunisation
|
|
GB0602336D0
|
|
Rapid elisa
|
|
GB0524782D0
|
|
Analysis of samples
|
|
GB0524066D0
|
|
741 ii
|
|
GB0523923D0
|
|
Adjuvants and antigens
|
|
GB0522765D0
|
|
Combination vaccine manufacture
|
|
GB0522599D0
|
|
Adjuvants and antigens
|
|
GB0522601D0
|
|
Adjuvanted influenza vaccines and kits
|
|
GB0522600D0
|
|
Rapid elisa
|
|
GB0522303D0
|
|
Culture method
|
|
GB0517719D0
|
|
Vaccines containing pili
|
|
GB0517353D0
|
|
Modification of capsular saccharides
|
|
GB0515906D0
|
|
Mixtures of antigen and adjuvant
|
|
GB0509318D0
|
|
TCR-independent activation of T cells
|
|
WO2005105140A2
|
|
Meningococcal conjugate vaccination
|
|
GB0505518D0
|
|
Combination vaccines with whole cell pertussis antigen
|
|
GB0502095D0
|
|
Conjugation of streptococcal capsular saccharides
|
